PTSM: Pharmaceutical Technology Sourcing and Management-01-07-2009

Early development spending has decreased sharply as industry responds to the financial crisis.

Outsourcing sterile manufacturing involves an integrated approach in product life-cycle management.

Achieving double-digit growth through 2011, biotech-based active pharmaceutical ingredients (APIs) are expected to far surpass growth rates for chemically synthesized APIs.